Clin Transl Allergy:哮喘、特应性皮炎和变应性鼻炎与围产期精神障碍的关系

2022-01-21 医路坦克 MedSci原创

围产期是女性一个明显而重要的时期,受荷尔蒙和免疫分子变化的推动,导致精神障碍的易感性增加。受孕前有哮喘、特应性皮炎和过敏性鼻炎的病史与围产期精神障碍的风险增加有关。

围产期是女性一个明显而重要的时期,受荷尔蒙和免疫分子变化的推动,导致精神障碍的易感性增加。围产期精神障碍影响着超过10%的孕妇和产后妇女,既与母亲的不良妊娠结局有关,也与儿童的行为问题有关。尽管潜在的机制尚不清楚,但围产期精神障碍与几种免疫相关疾病有关,如炎症性肠道疾病、先兆子痫和妊娠期糖尿病特应性疾病的特点是炎症反应失调,可能导致围产期精神障碍的发作,但其影响尚不清楚,本研究调查了特应性疾病的病史是否以及在多大程度上与新发的围产期精神障碍有关。

近日,发表在Clin Transl Allergy杂志上的一项研究,通过基于人群的登记,我们确定了丹麦1978-2016年间所有生下独生子女的初产妇女(n=937,422)。怀孕前因哮喘、特应性皮炎和过敏性鼻炎这三种主要特应性疾病而接触过医院。主要结果是怀孕期间和产后一年内因精神障碍而在医院接触过的任何人,进一步分为情感性障碍、神经症性、应激性和躯体形式障碍以及药物滥用。

在怀孕期间和产后一年内因精神障碍而在医院接触过的情况,分为情感性障碍、神经症性障碍、应激性和躯体形式障碍以及药物滥用,以及在怀孕前因哮喘、特应性皮炎和过敏性鼻炎而与医院接触的情况。根据历年、生育年龄、教育程度、居住地和查尔森共病指数进行了校正后的Cox回归分析。

结果显示:共有24,016名(2.6%)妇女在conception(asthma,1.7%;atopicdermatitis,0.6%;and变应性鼻炎之前至少诊断出三种特应性疾病中的一种(0.8%)。暴露于哮喘、特应性皮炎或变应性鼻炎与围产期精神障碍的风险增加37%相关(危险比[HR],1.37;95%可信区间[CI],1.27-1.49)。特应性疾病与医院接触越频繁的妇女风险越高(HR,1.8;95%CI为1.3 7~2.35;≥为5倍),有特应性疾病住院接触史(HR为1.74;95%CI为1.48~2.0 6;受孕前2年内)。哮喘与神经性、应激相关和躯体形式障碍(HR,1.40;95%CI,1.21-1.62)和特应性皮炎与药物滥用(HR,1.62;95%CI,1.12-2.34)之间有特定的相关性。

综上,受孕前有哮喘、特应性皮炎和过敏性鼻炎的病史与围产期精神障碍的风险增加有关。怀孕前患有特应性疾病的妇女可能会从系统的心理健康监测中受益。

文献来源:

Ren T,  Chen J,  Yu Y,The association of asthma,atopic dermatitis,and allergic rhinitis with peripartum mental disorders,Clin Transl Allergy 2021 Dec;11(10)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1657598, encodeId=6311165e59841, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 08 21:33:30 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067606, encodeId=6459206e606e8, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sat Jul 30 19:33:30 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187815, encodeId=a189118e81557, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Mon Jan 24 21:03:16 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323330, encodeId=f6211323330d8, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329592, encodeId=8179132959263, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-08-08 bsmagic9140
  2. [GetPortalCommentsPageByObjectIdResponse(id=1657598, encodeId=6311165e59841, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 08 21:33:30 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067606, encodeId=6459206e606e8, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sat Jul 30 19:33:30 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187815, encodeId=a189118e81557, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Mon Jan 24 21:03:16 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323330, encodeId=f6211323330d8, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329592, encodeId=8179132959263, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1657598, encodeId=6311165e59841, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 08 21:33:30 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067606, encodeId=6459206e606e8, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sat Jul 30 19:33:30 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187815, encodeId=a189118e81557, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Mon Jan 24 21:03:16 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323330, encodeId=f6211323330d8, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329592, encodeId=8179132959263, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-24 屋顶瞄爱赏月

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1657598, encodeId=6311165e59841, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 08 21:33:30 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067606, encodeId=6459206e606e8, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sat Jul 30 19:33:30 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187815, encodeId=a189118e81557, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Mon Jan 24 21:03:16 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323330, encodeId=f6211323330d8, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329592, encodeId=8179132959263, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1657598, encodeId=6311165e59841, content=<a href='/topic/show?id=3ca31e71903' target=_blank style='color:#2F92EE;'>#TRA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17719, encryptionId=3ca31e71903, topicName=TRA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=757b24868428, createdName=bsmagic9140, createdTime=Mon Aug 08 21:33:30 CST 2022, time=2022-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2067606, encodeId=6459206e606e8, content=<a href='/topic/show?id=d0841e75535' target=_blank style='color:#2F92EE;'>#Transl#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17755, encryptionId=d0841e75535, topicName=Transl)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sat Jul 30 19:33:30 CST 2022, time=2022-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187815, encodeId=a189118e81557, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211111/81c0b64745c644319545ec26d7ef0b34/9ddb2864d5df4dd9bf4305e380bffc96.jpg, createdBy=c7835705079, createdName=屋顶瞄爱赏月, createdTime=Mon Jan 24 21:03:16 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323330, encodeId=f6211323330d8, content=<a href='/topic/show?id=5332380998f' target=_blank style='color:#2F92EE;'>#变应性鼻炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38099, encryptionId=5332380998f, topicName=变应性鼻炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0a3a2500014, createdName=fmq_28614553, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329592, encodeId=8179132959263, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Fri Jan 21 14:33:30 CST 2022, time=2022-01-21, status=1, ipAttribution=)]
    2022-01-21 膀胱癌

相关资讯

Lancet Respir Med:近期哮喘发作患者感染COVID-19后发生不良结局的风险加大

近期哮喘发作患者应该是COVID-19增强疫苗的优先群体。

JACI:寄生虫感染可能会增加儿童气道高反应性的发生风险

儿童感染蛔虫可能增加支气管高反应性的发生风险,成人寄生虫感染可能增加过敏症的风险。

JAMA Pediatrics:针对社会风险的干预措施与哮喘儿童住院率降低有关

基于这项研究,解决社会风险可能是改善儿童哮喘患者健康结局的重要措施。同时倡导在社区层面实施解决SDOH领域的政策。

持续mepolizumab治疗能够让重度嗜酸性粒细胞性哮喘患者长期获益

持续mepolizumab治疗能够让重度嗜酸性粒细胞性哮喘患者获益,并支持血嗜酸性粒细胞作为mepolizumab治疗的生物标志物。

Radiology:CT和氦3 MRI发现黏液栓塞可能是哮喘通气缺陷的重要原因

气道黏液堵塞与高极化氦3 MRI示同一支气管肺段通气减少有关,提示黏液栓塞可能是哮喘通气缺陷的重要原因。

Sleep Medicine Reviews:哮喘与OSA的相互作用会加剧疾病的严重性

本综述总结了成人和儿童的哮喘和OSA之间相互影响的证据,重点关注诊断和治疗挑战并强调了进一步研究的必要性。